Browse by category

Helix model can predict 12-month weight loss response of semaglutide in diverse populations

Helix has unveiled new clinical research at the American Society of Human Genetics (ASHG) 2024 Annual Meeting, featuring a novel...

Journal Watch 13/11/2024

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

IFSO Bariatric Endoscopy Committee endorses endoscopic sleeve gastroplasty as an effective and valuable treatment for obesity

The IFSO Bariatric Endoscopy Committee has endorsed endoscopic sleeve gastroplasty (ESG) as an effective and valuable treatment for...

BMS reduces obesity-related pregnancy complications but introduces potential risks that may result in adverse outcomes

Whilst bariatric and metabolic surgery (BMS) can reduce obesity-related pregnancy complications, it can inadvertently result in an...

Anaemia remains a significant condition ten years after bariatric surgery

Anaemia remains a significant but still manageable condition five and ten years after bariatric surgery, but despite the prescription of...

Ascletis' announces promising results for ASC47 adipose-targeted THRβ

Ascletis Pharma has announced that results of its Phase I single ascending dose (SAD) study in Australia in subjects with elevated...

BMS may help reduce heart failure-related risk factors

Metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage...

GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour

Patients on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - Victoza (Liraglutide 1.8mg), Saxenda (Liraglutide 3mg), Ozempic...

Bariatric surgery induces changes in taste perception, desire and enjoyment of flavours

The majority of participants experience changes in taste perception, desire, and enjoyment of flavours after undergoing sleeve...

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss

Hanmi Pharm has announced promising research results for its novel obesity treatment, HM17321. According to the company, this...

Obesity-related brain changes can be reversed after bariatric surgery

19 minutes ago

Verge Genomics reveals VRG201 as its candidate for long-term weight management and metabolic homeostasis

30 minutes ago

Structure Therapeutics selects oral small molecule amylin receptor agonist ACCG-2671 for obesity treatment

59 minutes ago

Weekly Digest